載入...
Development of a Bestatin-SAHA Hybrid with Dual Inhibitory Activity against APN and HDAC
With five histone deacetylase (HDAC) inhibitors approved for cancer treatment, proteolysis-targeting chimeras (PROTACs) for degradation of HDAC are emerging as an alternative strategy for HDAC-targeted therapeutic intervention. Herein, three bestatin-based hydroxamic acids (P1, P2 and P3) were desig...
Na minha lista:
| 發表在: | Molecules |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7662900/ https://ncbi.nlm.nih.gov/pubmed/33126591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25214991 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|